Search

Your search keyword '"Martin, Charlotte"' showing total 822 results

Search Constraints

Start Over You searched for: Author "Martin, Charlotte" Remove constraint Author: "Martin, Charlotte"
822 results on '"Martin, Charlotte"'

Search Results

1. Structural basis of μ-opioid receptor targeting by a nanobody antagonist.

2. Robotic microinjection enables large-scale transgenic studies of Caenorhabditis elegans

3. Orai3 Calcium Channel Contributes to Oral/Oropharyngeal Cancer Stemness through the Elevation of ID1 Expression.

4. Safety and immunogenicity of the Ad26/protein preF RSV vaccine in adults aged 18 to 59 years with and without at-risk comorbidities for severe respiratory syncytial virus disease: A phase 3, randomized, controlled, immunobridging trial

5. La gangstérisation du monde

12. Prognostic factors of the synovial sarcoma of the extremities: imaging does matter

14. Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial

15. Epidemiological and clinical characteristics of patients with monkeypox in the GeoSentinel Network: a cross-sectional study

16. Identification of small molecule antivirals against HTLV-1 by targeting the hDLG1-Tax-1 protein-protein interaction

17. Protection against COVID-19 hospitalisation conferred by primary-series vaccination with AZD1222 in non-boosted individuals: first vaccine effectiveness results of the European COVIDRIVE study and meta-regression analysis

20. Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis

23. Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

24. Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

26. Multitarget μ-Opioid Receptor Agonists─Neuropeptide FF Receptor Antagonists Induce Potent Antinociception with Reduced Adverse Side Effects

31. BRCA2 Hypomorphic Missense Variants Confer Moderate Risks of Breast Cancer

32. Fluorinated Peptide Hydrogels Result in Longer In VivoResidence Time after Subcutaneous Administration

34. The BRCA2 R2645G variant increases DNA binding and induces hyper-recombination.

37. Effectiveness of the BNT162b2 XBB.1.5-Adapted Vaccine Against COVID-19 Hospitalization Related to the JN.1 Variant in Europe: A Test-Negative Case-Control Study Using the id.Drive Platform

39. Clinical Management of Argentine Hemorrhagic Fever using Ribavirin and Favipiravir, Belgium, 2020

40. Longitudinal study based on a safety registry for malaria patients treated with artenimol–piperaquine in six European countries

43. Failure of artemether-lumefantrine therapy in travellers returning to Belgium with Plasmodium falciparum malaria: an observational case series with genomic analysis.

45. Failure of artemether-lumefantrine therapy in travellers returning to Belgium with Plasmodium falciparum malaria: an observational case series with genomic analysis

46. The BRCA2 R2645G variant increases DNA binding and induces hyper-recombination

47. Structural Basis of μ-Opioid Receptor-Targeting by a Nanobody Antagonist

48. Liens en pédopsychiatrie et impacts de la crise sanitaire de 2019

50. First Cases of Coronavirus Disease 2019 (COVID-19) in the WHO European Region, 24 January to 21 February 2020

Catalog

Books, media, physical & digital resources